IN8bio, Inc. (INAB) vs Theriva Biologics, Inc. (TOVX)
IN8bio, Inc. and Theriva Biologics, Inc. are both Biotechnology companies. IN8bio, Inc. and Theriva Biologics, Inc. are of similar size ($11.1M and $10.6M). IN8bio, Inc. has negative trailing earnings, so its P/E is not meaningful; Theriva Biologics, Inc. trades at 0.2×. Across the 10 metrics below, Theriva Biologics, Inc. leads on 6 and IN8bio, Inc. on 4.
Valuation
Profitability
| Metric | INAB | TOVX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (111.11%) | (115.11%) | (57.72%) |
| Return on assets | (90.80%) | (37.14%) | (49.22%) |
| Return on invested capital | (2,948.56%) | (301.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack